These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23692413)

  • 1. Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.
    Amodio N; Di Martino MT; Neri A; Tagliaferri P; Tassone P
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S125-37. PubMed ID: 23692413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
    Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
    Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ncRNA in multiple myeloma.
    Leng S; Qu H; Lv X; Liu X
    Biomark Med; 2022 Nov; 16(16):1181-1191. PubMed ID: 36688304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging pathways as individualized therapeutic target of multiple myeloma.
    Misso G; Zappavigna S; Castellano M; De Rosa G; Di Martino MT; Tagliaferri P; Tassone P; Caraglia M
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S95-109. PubMed ID: 23738692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic microenvironment and personalized treatment in multiple myeloma.
    Rossi M; Botta C; Correale P; Tassone P; Tagliaferri P
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S83-93. PubMed ID: 23692463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of noncoding RNAs in drug resistance in multiple myeloma.
    Li J; Zou J; Wan X; Sun C; Chu Z; Hu Y
    J Cell Physiol; 2020 Nov; 235(11):7681-7695. PubMed ID: 32324301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways.
    Hashemi M; Roshanzamir SM; Paskeh MDA; Karimian SS; Mahdavi MS; Kheirabad SK; Naeemi S; Taheriazam A; Salimimoghaddam S; Entezari M; Mirzaei S; Samarghandian S
    Eur J Pharmacol; 2023 Feb; 941():175380. PubMed ID: 36627099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Roles of Non-Coding RNAs in Colorectal Cancer.
    Wang J; Song YX; Ma B; Wang JJ; Sun JX; Chen XW; Zhao JH; Yang YC; Wang ZN
    Int J Mol Sci; 2015 Aug; 16(8):19886-919. PubMed ID: 26307974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
    Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
    Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma.
    Evans RP; Dueck G; Sidhu R; Ghosh S; Toman I; Loree J; Bahlis N; Klimowicz AC; Fung J; Jung M; Lai R; Pilarski LM; Belch AR; Reiman T
    Leuk Res; 2011 Dec; 35(12):1637-43. PubMed ID: 21816470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-coding RNA in fungi--a review].
    Li L; Luo Y; Li S
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):790-7. PubMed ID: 24341270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNAs in endometriosis: a narrative review.
    Panir K; Schjenken JE; Robertson SA; Hull ML
    Hum Reprod Update; 2018 Jul; 24(4):497-515. PubMed ID: 29697794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs in prostate cancer: the long and the short of it.
    Bolton EM; Tuzova AV; Walsh AL; Lynch T; Perry AS
    Clin Cancer Res; 2014 Jan; 20(1):35-43. PubMed ID: 24146262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of miRNAs as biomarkers for multiple myeloma.
    Rocci A; Hofmeister CC; Pichiorri F
    Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking the central dogma: noncoding RNAs are biologically relevant.
    Robinson VL
    Urol Oncol; 2009; 27(3):304-6. PubMed ID: 19414118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs and respiratory disease.
    Mestdagh P; Vandesompele J; Brusselle G; Vermaelen K
    Thorax; 2015 Apr; 70(4):388-90. PubMed ID: 25378544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panobinostat for the treatment of multiple myeloma.
    Neri P; Bahlis NJ; Lonial S
    Expert Opin Investig Drugs; 2012 May; 21(5):733-47. PubMed ID: 22404247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs and cancer: new paradigms in oncology.
    Lee SK; Calin GA
    Discov Med; 2011 Mar; 11(58):245-54. PubMed ID: 21447283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging biological insights and novel treatment strategies in multiple myeloma.
    Gentile M; Recchia AG; Mazzone C; Morabito F
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):407-38. PubMed ID: 22920042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.